Directors’ Dealings | 15 May 2009 16:53

DGAP-DD: Biotest AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. —————————————————————————— Details of the person subject to the disclosure requirement Last name: Dr. Schulze First name: Frank Company: Biotest AG Position: Head of Microbiology Division Information about the transaction with duty of notification Description of the financial instrument: Preference Shares ISIN/WKN of the financial instrument: DE0005227235 Type of transaction: Buy Date: 15.05.2009 Price: 30.89 Currency: EUR No. of items: 650 Total amount traded: 20077.40 Place: Xetra, Stuttgart Explanation for publication: 20 Shares Quote 30,49/Share Xetra 120 Shares Quote 30,48/Share Xetra 510 Shares Quote 31,00/Share Stuttgart Information about the company with duty of publication Issuer: Biotest AG Landsteinerstraße 5 63303 Dreieich Deutschland ISIN: DE0005227235 WKN: 522723 End of Directors’ Dealings Notification (c) DGAP 15.05.2009 Financial News transmitted by DGAP ID 9483